InsiderSignal.AI

InsiderSignal.ai

NMTC - Neuroone Medical Technologies Corp

Insider Purchase by Wambeke David J. (Chief Business Officer)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

1 month ago, Wambeke David J., serving as Chief Business Officer at Neuroone Medical Technologies Corp (NMTC), purchased 1,000,000 shares at $0.67 per share, for a total transaction value of $670,400.00. Following this transaction, Wambeke David J. now holds 1,000,000 shares of NMTC.

The trade was executed on Sunday, March 1, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 3, 2026, 2 days after the trade was made.

Neuroone Medical Technologies Corp operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Wambeke David J.

Chief Business Officer

David J. Wambeke is the Chief Business Officer of NeuroOne Medical Technologies Corp (NASDAQ: NMTC), a position he recently assumed, as indicated by his initial Form 3 filing with the SEC.[[3]](https://www.stocktitan.net/sec-filings/NMTC/form-3-neuroone-medical-technologies-corp-initial-statement-of-benefi-6e709d551992.html) On March 1, 2026, Wambeke purchased 1,000,000 shares of NMTC common stock at $0.6704 per share, totaling $670,400, and acquired 500,000 stock options with an exercise price of $0.6704, vesting starting March 1, 2027 and expiring February 29, 2036.[[2]](https://www.investing.com/news/insider-trading-news/neuroone-medical-chief-business-officer-buys-670k-in-nmtc-93CH-4538030)[[6]](https://www.mexc.co/en-IN/news/844127)[[7]](https://whalewisdom.com/filing/wambeke-david-j-4-2026-03-03-084919-0500-nmtc) He resides at 7599 Anagram Drive, Eden Prairie, MN 55344.[[7]](https://whalewisdom.com/filing/wambeke-david-j-4-2026-03-03-084919-0500-nmtc) In his role, Wambeke is expected to drive the company's drug-related initiatives and business growth, amid NMTC's recent financial developments including Q1 Fiscal 2026 revenue of $2.9 million and product revenue growth from $3.5 million in FY2024 to $9.1 million in FY2025, driven by the OneRF Ablation System.[[2]](https://www.investing.com/news/insider-trading-news/neuroone-medical-chief-business-officer-buys-670k-in-nmtc-93CH-4538030)[[6]](https://www.mexc.co/en-IN/news/844127)

View full insider profile →

Trade Price

$0.67

Quantity

1,000,000

Total Value

$670,400.00

Shares Owned

1,000,000

Trade Date

Sunday, March 1, 2026

49 days ago

SEC Filing Date

Tuesday, March 3, 2026

Filed 2 days after trade

HEALTHCAREMEDICAL DEVICES

About Neuroone Medical Technologies Corp

Company Overview

No company information available
View news mentioning NMTC

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4459051

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime